Molecule Information
General Information of the Molecule (ID: Mol01000)
Name |
Melanoma antigen A 4 (MAGE4)
,Homo sapiens
|
||||
---|---|---|---|---|---|
Synonyms |
MAGEA4; MAGEA4); mRNA
Click to Show/Hide
|
||||
Molecule Type |
Protein
|
||||
Gene Name |
MAGEA4
|
||||
Sequence |
MSSEQKSQHCKPEEGVEAQEEALGLVGAQAPTTEEQEAAVSSSSPLVPGTLEEVPAAESA
GPPQSPQGASALPTTISFTCWRQPNEGSSSQEEEGPSTSPDAESLFREALSNKVDELAHF LLRKYRAKELVTKAEMLERVIKNYKRCFPVIFGKASESLKMIFGIDVKEVDPTSNTYTLV TCLGLSYDGLLGNNQIFPKTGLLIIVLGTIAMEGDSASEEEIWEELGVMGVYDGREHTVY GEPRKLLTQDWVQENYLEYRQVPGSNPARYEFLWGPRALAETSYVKVLEHVVRVNARVRI AYPSLREAALLEEEEGV Click to Show/Hide
|
||||
Uniprot ID | |||||
Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
UAPP: Unusual Activation of Pro-survival Pathway
Drug Resistance Data Categorized by Drug
Approved Drug(s)
4 drug(s) in total
Carboplatin
Drug Sensitivity Data Categorized by Their Corresponding Mechanisms | ||||
Unusual Activation of Pro-survival Pathway (UAPP) | ||||
Disease Class: Retinoblastoma | [1] | |||
Sensitive Disease | Retinoblastoma [ICD-11: 2D02.2] | |||
Sensitive Drug | Carboplatin | |||
Molecule Alteration | Expression | Up-regulation |
||
Experimental Note | Revealed Based on the Cell Line Data | |||
Cell Pathway Regulation | Cell apoptosis | Activation | hsa04210 | |
MAGE-A/p53 signaling pathway | Regulation | hsa04115 | ||
In Vitro Model | HXO-Rb44 cells | Retina | Homo sapiens (Human) | CVCL_D542 |
SO-Rb50 cells | Retina | Homo sapiens (Human) | CVCL_D543 | |
WERI-Rb-1 cells | Retina | Homo sapiens (Human) | CVCL_1792 | |
Y79 cells | Retina | Homo sapiens (Human) | CVCL_1893 | |
Experiment for Molecule Alteration |
Western blot analysis; RT-qPCR | |||
Experiment for Drug Resistance |
Freedom Evolyzer-2200 Enzyme-Linked Immunometric meter; Flow cytometry assay | |||
Mechanism Description | miR-34a may function as a tumor suppressor for RB by targeting MAGE-A and upregulating p53 expression to enhance cell apoptosis and chemosensitivity (Carboplatin; Etoposide; Adriamycin; vincristine). |
Doxorubicin
Drug Sensitivity Data Categorized by Their Corresponding Mechanisms | ||||
Unusual Activation of Pro-survival Pathway (UAPP) | ||||
Disease Class: Retinoblastoma | [1] | |||
Sensitive Disease | Retinoblastoma [ICD-11: 2D02.2] | |||
Sensitive Drug | Doxorubicin | |||
Molecule Alteration | Expression | Up-regulation |
||
Experimental Note | Revealed Based on the Cell Line Data | |||
Cell Pathway Regulation | Cell apoptosis | Activation | hsa04210 | |
MAGE-A/p53 signaling pathway | Regulation | hsa04115 | ||
In Vitro Model | HXO-Rb44 cells | Retina | Homo sapiens (Human) | CVCL_D542 |
SO-Rb50 cells | Retina | Homo sapiens (Human) | CVCL_D543 | |
WERI-Rb-1 cells | Retina | Homo sapiens (Human) | CVCL_1792 | |
Y79 cells | Retina | Homo sapiens (Human) | CVCL_1893 | |
Experiment for Molecule Alteration |
Western blot analysis; RT-qPCR | |||
Experiment for Drug Resistance |
Freedom Evolyzer-2200 Enzyme-Linked Immunometric meter; Flow cytometry assay | |||
Mechanism Description | miR-34a may function as a tumor suppressor for RB by targeting MAGE-A and upregulating p53 expression to enhance cell apoptosis and chemosensitivity (Carboplatin; Etoposide; Adriamycin; vincristine). |
Etoposide
Drug Sensitivity Data Categorized by Their Corresponding Mechanisms | ||||
Unusual Activation of Pro-survival Pathway (UAPP) | ||||
Disease Class: Retinoblastoma | [1] | |||
Sensitive Disease | Retinoblastoma [ICD-11: 2D02.2] | |||
Sensitive Drug | Etoposide | |||
Molecule Alteration | Expression | Up-regulation |
||
Experimental Note | Revealed Based on the Cell Line Data | |||
Cell Pathway Regulation | Cell apoptosis | Activation | hsa04210 | |
MAGE-A/p53 signaling pathway | Regulation | hsa04115 | ||
In Vitro Model | HXO-Rb44 cells | Retina | Homo sapiens (Human) | CVCL_D542 |
SO-Rb50 cells | Retina | Homo sapiens (Human) | CVCL_D543 | |
WERI-Rb-1 cells | Retina | Homo sapiens (Human) | CVCL_1792 | |
Y79 cells | Retina | Homo sapiens (Human) | CVCL_1893 | |
Experiment for Molecule Alteration |
Western blot analysis; RT-qPCR | |||
Experiment for Drug Resistance |
Freedom Evolyzer-2200 Enzyme-Linked Immunometric meter; Flow cytometry assay | |||
Mechanism Description | miR-34a may function as a tumor suppressor for RB by targeting MAGE-A and upregulating p53 expression to enhance cell apoptosis and chemosensitivity (Carboplatin; Etoposide; Adriamycin; vincristine). |
Vincristine
Drug Sensitivity Data Categorized by Their Corresponding Mechanisms | ||||
Unusual Activation of Pro-survival Pathway (UAPP) | ||||
Disease Class: Retinoblastoma | [1] | |||
Sensitive Disease | Retinoblastoma [ICD-11: 2D02.2] | |||
Sensitive Drug | Vincristine | |||
Molecule Alteration | Expression | Up-regulation |
||
Experimental Note | Revealed Based on the Cell Line Data | |||
Cell Pathway Regulation | Cell apoptosis | Activation | hsa04210 | |
MAGE-A/p53 signaling pathway | Regulation | hsa04115 | ||
In Vitro Model | HXO-Rb44 cells | Retina | Homo sapiens (Human) | CVCL_D542 |
SO-Rb50 cells | Retina | Homo sapiens (Human) | CVCL_D543 | |
WERI-Rb-1 cells | Retina | Homo sapiens (Human) | CVCL_1792 | |
Y79 cells | Retina | Homo sapiens (Human) | CVCL_1893 | |
Experiment for Molecule Alteration |
Western blot analysis; RT-qPCR | |||
Experiment for Drug Resistance |
Freedom Evolyzer-2200 Enzyme-Linked Immunometric meter; Flow cytometry assay | |||
Mechanism Description | miR-34a may function as a tumor suppressor for RB by targeting MAGE-A and upregulating p53 expression to enhance cell apoptosis and chemosensitivity (Carboplatin; Etoposide; Adriamycin; vincristine). |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.